If you've watched the news around medical device security and cybersecurity, you probably know that malicious hackers could kill you through your insulin pump. FDA was prompted last summer to urge device makers to take cybersecurity more seriously as part of their development process. Medical device security is on more and more people's minds. But when did the trouble start? And is industry already too far behind the curve?
Google has been anxiously pacing the medtech sidelines for some time. Notably, the company dabbled in personal health records through the now-defunct Google Health, watched its Google Glass transform surgery, and, most recently, launched the health and wellbeing-focused company Calico. With the recent unveiling of the Google[x] smart contact lens project, however, the company has officially stepped onto the field and is ready to play ball.
Following rampant speculation spurred by a meeting...
Wearable computing might be tech's latest buzzword today, but implants are next. At the 2014 Consumer Electronics Show (CES) companies from a wide range of sectors showcased the latest and greatest wearable gadgets; everything from advanced baby monitoring systems to high-tech mood ring-esque clothing. Intel evenn announced a competition offered up $1.4 million in prize money to developers that bring them the best wearable tech. So, in the typical Silicon Valley fashion of hype-heavy proclamations, the future of tech has officially been announced: Wearable technology shall be the future.
A new standard by West Conshohocken, PA–based ASTM has been developed to create consistency in the way vascular scaffolds are evaluated from the manufacturing stage to absorption in the body. To guide the medical device industry, academia, government agencies, and others involved in evaluating the performance of vascular scaffolds, ASTM F3036, or Guide for Testing Absorbable Stents, provides criteria for evaluating absorbable stents’ physical and mechanical properties.
|Abbott Vascular's polymer-based Absorb bioresorbable stent.|
Heading into 2014, medtech doomsday preppers are busy developing survival strategies for the perceived Obamacare apocalypse while others are adopting a wait-and-see approach. But amid the doom and gloom, there are several beacons of hope offering opportunities for medtech success.
In Vitro Diagnostics. While many markets may struggle under the Affordable Care Act (ACA), the IVD industry is predicted to get a welcome boost. “IVD benefits more than most medtech industries from the ACA,...
In a recent radio interview with KCRW, Stuart Karten, principal of Marina Del Rey, CA-based Karten Design, said that the restrictions imposed by Obamacare are a blessing in disguise for medical device designers. While many bemoan the impact of the medical device tax, Karten told KCRW that anticipation of the tax is a good thing for new products entering the market.
The trade association’s president and CEO muses about the state of the medical device industry.
By Stephen J. Ubl
Looking back on 2013, I’m struck by all the positive progress that has been made on some long-standing medical device industry issues. Putting aside the device tax for a moment, there are discreet issues that typically fly below most people’s radar but are very important to certain segments of the medical technology community. For example, getting CMS to recognize and begin to address charge compression, a technical calculation that inappropriately reduced Medicare payment for many device-related procedures, was a step forward. Likewise, HHS’s Office of the Inspector General issued a Special Fraud Alert and...
Conducting business as usual wasn’t an option for the medical device industry in 2013. Healthcare reform and a challenging regulatory environment, coupled with the growing impact of globalization, consumerization, and mHealth, forced manufacturers to reevaluate their businesses in order to compete in a new era of healthcare. And while an ominous cloud of uncertainty hung over the medtech industry this year, one concept became crystal clear: Adapt or risk becoming obsolete.
The impetus for much of the medtech makeover this year, of course, was the Affordable Care Act (ACA). With its emphasis on value- or outcomes-based healthcare and reducing healthcare costs, ...
MD+DI takes a look back at the our most popular stories from 2013. Catch up on some of the big stories you may have missed.
Futurist Thomas Frey predicted that, by 2030, 2 billion jobs will be lost to automation. Here's one technology that could very much be responsible for this in the manufacturing sector.